245 related articles for article (PubMed ID: 18027161)
1. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
Chien JW; Au DH; Barnett MJ; Goodman GE
COPD; 2007 Dec; 4(4):339-46. PubMed ID: 18027161
[TBL] [Abstract][Full Text] [Related]
2. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
[TBL] [Abstract][Full Text] [Related]
3. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers.
Omenn GS; Goodman GE; Thornquist MD; Rosenstock L; Barnhart S; Gylys-Colwell I; Metch B; Lund B
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):381-7. PubMed ID: 8348062
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal decline in lung function in former asbestos exposed workers.
Algranti E; Mendonça EM; Hnizdo E; De Capitani EM; Freitas JB; Raile V; Bussacos MA
Occup Environ Med; 2013 Jan; 70(1):15-21. PubMed ID: 23014595
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.
Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J
IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118
[No Abstract] [Full Text] [Related]
6. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
7. Body mass index, weight gain, and other determinants of lung function decline in adult asthma.
Marcon A; Corsico A; Cazzoletti L; Bugiani M; Accordini S; Almar E; Cerveri I; Gislason D; Gulsvik A; Janson C; Jarvis D; Martínez-Moratalla J; Pin I; de Marco R;
J Allergy Clin Immunol; 2009 May; 123(5):1069-74, 1074.e1-4. PubMed ID: 19321196
[TBL] [Abstract][Full Text] [Related]
8. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Hammar S
N Engl J Med; 1996 May; 334(18):1150-5. PubMed ID: 8602180
[TBL] [Abstract][Full Text] [Related]
9. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
10. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
11. Evidence for excess colorectal cancer incidence among asbestos-exposed men in the Beta-Carotene and Retinol Efficacy Trial.
Aliyu OA; Cullen MR; Barnett MJ; Balmes JR; Cartmel B; Redlich CA; Brodkin CA; Barnhart S; Rosenstock L; Israel L; Goodman GE; Thornquist MD; Omenn GS
Am J Epidemiol; 2005 Nov; 162(9):868-78. PubMed ID: 16177148
[TBL] [Abstract][Full Text] [Related]
12. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
[TBL] [Abstract][Full Text] [Related]
13. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers.
Goodman GE; Omenn GS; Thornquist MD; Lund B; Metch B; Gylys-Colwell I
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):389-96. PubMed ID: 8348063
[TBL] [Abstract][Full Text] [Related]
14. Population-based study of lung function and incidence of heart failure hospitalisations.
Engström G; Melander O; Hedblad B
Thorax; 2010 Jul; 65(7):633-8. PubMed ID: 20627923
[TBL] [Abstract][Full Text] [Related]
15. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
16. [A follow-up study of lung function among ex-asbestos workers with and without pleural plaques].
Rui F; De Zotti R; Negro C; Bovenzi M
Med Lav; 2004; 95(3):171-9. PubMed ID: 15293373
[TBL] [Abstract][Full Text] [Related]
17. Obstructive airway disease as a risk factor for asbestos-associated malignancy.
Harber P; Oren A; Mohsenifar Z; Lew M
J Occup Med; 1986 Feb; 28(2):82-6. PubMed ID: 3950787
[TBL] [Abstract][Full Text] [Related]
18. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.
Prindiville SA; Byers T; Hirsch FR; Franklin WA; Miller YE; Vu KO; Wolf HJ; Barón AE; Shroyer KR; Zeng C; Kennedy TC; Bunn PA
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):987-93. PubMed ID: 14578133
[TBL] [Abstract][Full Text] [Related]
19. Reduced lung function predicts increased fatality in future cardiac events. A population-based study.
Engström G; Hedblad B; Janzon L
J Intern Med; 2006 Dec; 260(6):560-7. PubMed ID: 17116007
[TBL] [Abstract][Full Text] [Related]
20. Spirometric abnormalities among asbestos insulation workers.
Lerman Y; Seidman H; Gelb S; Miller A; Selikoff IJ
J Occup Med; 1988 Mar; 30(3):228-33. PubMed ID: 3361360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
